INDIGO Home University of Illinois at Urbana-Champaign logo uic building uic pavilion uic student center

The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS

Show full item record

Bookmark or cite this item: http://hdl.handle.net/10027/19863

Files in this item

File Description Format
PDF p38a mitogen-activated.pdf (4MB) Main article PDF
Title: The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS
Author(s): Chen, S.H.; Biswas, S.; Selvaraj, V.; Liu, X-B; Sohn, J.; Jiang, P.
Abstract: The p38α mitogen-activated protein kinase (MAPK) is one of the serine/threonine kinases regulating a variety of biological processes, including cell-type specification, differentiation and migration. Previous in vitro studies using pharmacological inhibitors suggested that p38 MAPK is essential for oligodendrocyte (OL) differentiation and myelination. To investigate the specific roles of p38α MAPK in OL development and myelination in vivo, we generated p38α conditional knockout (CKO) mice under the PLP and nerve/glial antigen 2 (NG2) gene promoters, as these genes are specifically expressed in OL progenitor cells (OPCs). Our data revealed that myelin synthesis was completely inhibited in OLs differentiated from primary OPC cultures derived from the NG2 Cre-p38α CKO mouse brains. Although an in vivo myelination defect was not obvious after gross examination of these mice, electron microscopic analysis showed that the ultrastructure of myelin bundles was severely impaired. Moreover, the onset of myelination in the corpus callosum was delayed in the knockout mice compared with p38α fl/fl control mice. A delay in OL differentiation in the central nervous system was observed with concomitant downregulation in the expression of OPC- and OLspecific genes such as Olig1 and Zfp488 during early postnatal development. OPC proliferation was not affected during this time. These data indicate that p38α is a positive regulator of OL differentiation and myelination. Unexpectedly, we observed an opposite effect of p38α on remyelination in the cuprizone-induced demyelination model. The p38α CKO mice exhibited better remyelination capability compared with p38α fl/fl mice following demyelination. The opposing roles of p38α in myelination and remyelination could be due to a strong anti-inflammatory effect of p38α or a dual reciprocal regulatory action of p38α on myelin formation during development and on remyelination after demyelination.
Issue Date: 2015-06
Publisher: Nature Publishing Group
Citation Info: Chung, S. H., Biswas, S., Selvaraj, V., Liu, X. B., Sohn, J., Jiang, P., Chen, C., Chmilewsky, F., Marzban, H., Horiuchi, M., Pleasure, D. E. and Deng, W. The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS. Cell death & disease 6.5 (2015): e1748. DOI: 10.1038/cddis.2015.119.
Type: Article
Description: This is the copy of an article published in Cell Death and Disease © 2015 Nature Publishing Group.
URI: http://hdl.handle.net/10027/19863
ISSN: 2041-4889
Sponsor: This work was, in part, supported by grants from the National Institutes of Health (R01NS061983, R01ES015988), National Multiple Sclerosis Society and Shriners Hospitals for Children to WD.
Date Available in INDIGO: 2015-11-09
 

This item appears in the following Collection(s)

Show full item record

Statistics

Country Code Views
United States of America 127
China 35
Russian Federation 18
Germany 13
Ukraine 9

Browse

My Account

Information

Access Key